Alyeska Investment Group
SGRY icon

Alyeska Investment Group’s Surgery Partners SGRY Stock Holding History

Alyeska Investment Group’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-66,352
Closed -$3.54M – 664
2021
Q4 		$3.54M Buy
+66,352
New +$3.08M 0.04% 345

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group's SGRY Position: Q1 2022 in Review

Alyeska Investment Group sold out of Surgery Partners (SGRY) in Q1 2022, closing a stake of 66,352 shares — an estimated $3.54M sold.

Alyeska Investment Group first reported a position in SGRY in Q4 2021 and held it in 1 quarter. The position peaked at $3.54M in Q4 2021. 149 funds tracked by Wall St. Rank hold SGRY as of Q1 2022.

  • Alyeska Investment Group reported no remaining Surgery Partners position as of Q1 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 66,352 Surgery Partners shares in Q1 2022, an estimated $3.54M.
  • Alyeska Investment Group first reported a position in Surgery Partners in Q4 2021 and held it in 1 quarter.
  • Alyeska Investment Group's Surgery Partners position peaked at $3.54M in Q4 2021.
  • 149 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2022.

Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.